154 related articles for article (PubMed ID: 15181979)
1. Neuropeptide Y and Y2-receptor are involved in development of diabetic retinopathy and retinal neovascularization.
Koulu M; Movafagh S; Tuohimaa J; Jaakkola U; Kallio J; Pesonen U; Geng Y; Karvonen MK; Vainio-Jylhä E; Pöllönen M; Kaipio-Salmi K; Seppälä H; Lee EW; Higgins RD; Zukowska Z
Ann Med; 2004; 36(3):232-40. PubMed ID: 15181979
[TBL] [Abstract][Full Text] [Related]
2. Neuropeptide Y expression in a mouse model of oxygen-induced retinopathy.
Yoon HZ; Yan Y; Geng Y; Higgins RD
Clin Exp Ophthalmol; 2002 Dec; 30(6):424-9. PubMed ID: 12427234
[TBL] [Abstract][Full Text] [Related]
3. Neuropeptide Y: a novel angiogenic factor from the sympathetic nerves and endothelium.
Zukowska-Grojec Z; Karwatowska-Prokopczuk E; Rose W; Rone J; Movafagh S; Ji H; Yeh Y; Chen WT; Kleinman HK; Grouzmann E; Grant DS
Circ Res; 1998 Jul; 83(2):187-95. PubMed ID: 9686758
[TBL] [Abstract][Full Text] [Related]
4. Neuropeptide Y induces ischemic angiogenesis and restores function of ischemic skeletal muscles.
Lee EW; Michalkiewicz M; Kitlinska J; Kalezic I; Switalska H; Yoo P; Sangkharat A; Ji H; Li L; Michalkiewicz T; Ljubisavljevic M; Johansson H; Grant DS; Zukowska Z
J Clin Invest; 2003 Jun; 111(12):1853-62. PubMed ID: 12813021
[TBL] [Abstract][Full Text] [Related]
5. Neuropeptide Y system in the retina: From localization to function.
Santos-Carvalho A; Ambrósio AF; Cavadas C
Prog Retin Eye Res; 2015 Jul; 47():19-37. PubMed ID: 25797468
[TBL] [Abstract][Full Text] [Related]
6. Functional interaction between neuropeptide Y receptors and modulation of calcium channels in the rat hippocampus.
Silva AP; Carvalho AP; Carvalho CM; Malva JO
Neuropharmacology; 2003 Feb; 44(2):282-92. PubMed ID: 12623227
[TBL] [Abstract][Full Text] [Related]
7. Differential actions of NPY on seizure modulation via Y1 and Y2 receptors: evidence from receptor knockout mice.
Lin EJ; Young D; Baer K; Herzog H; During MJ
Epilepsia; 2006 Apr; 47(4):773-80. PubMed ID: 16650144
[TBL] [Abstract][Full Text] [Related]
8. Emerging novel roles of neuropeptide Y in the retina: from neuromodulation to neuroprotection.
Santos-Carvalho A; Álvaro AR; Martins J; Ambrósio AF; Cavadas C
Prog Neurobiol; 2014 Jan; 112():70-9. PubMed ID: 24184719
[TBL] [Abstract][Full Text] [Related]
9. Neuropeptide Y does not reset the circadian clock in NPY Y2-/- mice.
Soscia SJ; Harrington ME
Neurosci Lett; 2005 Jan; 373(3):175-8. PubMed ID: 15619538
[TBL] [Abstract][Full Text] [Related]
10. Impact of type 1 diabetes mellitus and sitagliptin treatment on the neuropeptide Y system of rat retina.
Campos EJ; Martins J; Brudzewsky D; Correia S; Santiago AR; Woldbye DP; Ambrósio AF
Clin Exp Ophthalmol; 2018 Sep; 46(7):783-795. PubMed ID: 29442423
[TBL] [Abstract][Full Text] [Related]
11. The Leu7Pro polymorphism of the signal peptide of neuropeptide Y (NPY) gene is associated with increased levels of inflammatory markers preceding vascular complications in patients with type 2 diabetes.
Jaakkola U; Kakko T; Seppälä H; Vainio-Jylhä E; Vahlberg T; Raitakari OT; Kallio J
Microvasc Res; 2010 Dec; 80(3):433-9. PubMed ID: 20691708
[TBL] [Abstract][Full Text] [Related]
12. Combined deletion of Y1, Y2, and Y4 receptors prevents hypothalamic neuropeptide Y overexpression-induced hyperinsulinemia despite persistence of hyperphagia and obesity.
Lin EJ; Sainsbury A; Lee NJ; Boey D; Couzens M; Enriquez R; Slack K; Bland R; During MJ; Herzog H
Endocrinology; 2006 Nov; 147(11):5094-101. PubMed ID: 16873543
[TBL] [Abstract][Full Text] [Related]
13. Secretoneurin, substance P and neuropeptide Y in the oxygen-induced retinopathy in C57Bl/6N mice.
Schmid E; Nogalo M; Bechrakis NE; Fischer-Colbrie R; Tasan R; Sperk G; Theurl M; Beer AG; Kirchmair R; Herzog H; Troger J
Peptides; 2012 Oct; 37(2):252-7. PubMed ID: 22884536
[TBL] [Abstract][Full Text] [Related]
14. The ability of neuropeptide Y to mediate responses in the murine cutaneous microvasculature: an analysis of the contribution of Y1 and Y2 receptors.
Chu DQ; Cox HM; Costa SK; Herzog H; Brain SD
Br J Pharmacol; 2003 Sep; 140(2):422-30. PubMed ID: 12970079
[TBL] [Abstract][Full Text] [Related]
15. Neuropeptide Y and glutamatergic mechanisms in the amygdala and ventral hippocampus differentially mediate impaired social behavior in diabetic mice.
Ueda D; Yonemochi N; Kamata T; Kamei J; Waddington JL; Ikeda H
Behav Brain Res; 2021 May; 405():113195. PubMed ID: 33617904
[TBL] [Abstract][Full Text] [Related]
16. Neuropeptide Y contributes to innervation-dependent increase in I(Ca, L) via ventricular Y2 receptors.
Protas L; Robinson RB
Am J Physiol; 1999 Sep; 277(3):H940-6. PubMed ID: 10484414
[TBL] [Abstract][Full Text] [Related]
17. Characterization of vascular postsynaptic neuropeptide Y receptor function and regulation. 1. NPY-induced constriction in isolated rat femoral artery rings is mediated by both Y1 and Y2 receptors: evidence from benextramine protection studies.
Tessel RE; Miller DW; Misse GA; Dong X; Doughty MB
J Pharmacol Exp Ther; 1993 Apr; 265(1):172-7. PubMed ID: 8474004
[TBL] [Abstract][Full Text] [Related]
18. Distinct roles of the Y1 and Y2 receptors on neuropeptide Y-induced sensitization to sedation.
Naveilhan P; Canals JM; Arenas E; Ernfors P
J Neurochem; 2001 Sep; 78(6):1201-7. PubMed ID: 11579129
[TBL] [Abstract][Full Text] [Related]
19. The Leu7Pro polymorphism of neuropeptide Y is associated with younger age of onset of type 2 diabetes mellitus and increased risk for nephropathy in subjects with diabetic retinopathy.
Jaakkola U; Pesonen U; Vainio-Jylhä E; Koulu M; Pöllönen M; Kallio J
Exp Clin Endocrinol Diabetes; 2006 Apr; 114(4):147-52. PubMed ID: 16705546
[TBL] [Abstract][Full Text] [Related]
20. Of mice and men: neuropeptide Y and its receptors are associated with atherosclerotic lesion burden and vulnerability.
Li L; Najafi AH; Kitlinska JB; Neville R; Laredo J; Epstein SE; Burnett MS; Zukowska Z
J Cardiovasc Transl Res; 2011 Jun; 4(3):351-62. PubMed ID: 21468772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
